Diabetes co-existing with chronic liver disease: Clinical features and response to therapy

2007 ◽  
Vol 16 (2) ◽  
Author(s):  
EK Chuhwak ◽  
SD Pam
2019 ◽  
Vol 20 (-1) ◽  
pp. 104-104
Author(s):  
Tugba Sismanlar Eyuboglu ◽  
◽  
Deniz Dogru Ersoz ◽  
Erkan Cakir ◽  
Nazan Cobanoglu ◽  
...  

2019 ◽  
Vol 18 ◽  
pp. S145
Author(s):  
T. Sismanlar Eyuboglu ◽  
D. Dogru Ersoz ◽  
E. Cakır ◽  
N. Cobanoglu ◽  
S. Pekcan ◽  
...  

2015 ◽  
Vol 22 (2) ◽  
pp. 120-124
Author(s):  
Mohammad Murad Hossain ◽  
Md Abul Kashem Khandaker ◽  
Khan Abul Kalam Azad ◽  
Md Hafiz Sardar ◽  
Shudip Ranjan Deb ◽  
...  

Background: The liver biopsy is considered by many experts to be the most specific diagnostic tool used to assess the nature and severity of liver diseases such as hepatitis C. Liver biopsies are important for many reasons, such as accurate diagnosis or ruling out any coexisting liver diseases, staging and grading the severity of liver disease, treatment decisions, patient and provider reassurance, and as a benchmark for gauging future progression. Methods: In this observational study, 50 patients were recruited from different Medicine units of Dhaka Medical College Hospital, Dhaka, from May, 2008 to June, 2009. After preliminary selection of patients, a specific protocol was followed which include patients’ particulars, clinical features and clinical diagnosis, biochemical parameters, radiological and other investigative procedures and finally percutaneous needle biopsy of liver was done. The objective of the study was to establish the correlation of clinical presentation of chronic parenchymal liver disease with histopathological findings and establish liver biopsy as a tool for diagnosis. SPSS version 16.0 was used to analyze the data. Quantitative data were presented in the form of tables and figures. Chi-square test and student t test was done to find out the statistical significance. Results: Histopathologically chronic liver disease (CLD) was found to be the commonest lesion (pd”0.05), which was 24 (48%) followed by hepatocellular carcinoma 13(26%) and secondary deposit 02(4%). Eleven cases consist of other findings including normal. CLD commonly presented with loss of appetite (82%), Jaundice (74%), Weight loss (68%), hepatic facies (54%).Hepatocellular carcinoma commonly presented with hepatomegaly (100%), jaundice (61.84%), weight loss (76.92%), and ascites (53.85%). Hepatomegaly was constant feature (100%) of all secondary metastasis. Among two cases of secondary carcinoma one (50%) was adenocarcinoma and another one (50%) was anaplastic type. Out of 29 cases of clinically diagnosed chronic liver disease 24 cases were confirmed histopathologically which was statistically significant (pd”0.05). Conclusion: For the establishment of diagnosis and treatment it is mandatory to have a good correlation between clinical features and histopathological finding. Histopathology could detect diseases which were not considered clinically and specific management could only be done depending on histopathology. Therefore, if there is no contraindication, for confirmation of diagnosis liver biopsy still remains the corner stone modality. DOI: http://dx.doi.org/10.3329/jdmc.v22i2.21520 J Dhaka Medical College, Vol. 22, No.2, October, 2013, Page 120-124


2017 ◽  
Vol 01 (04) ◽  
pp. 241-247
Author(s):  
Anthony Esparaz ◽  
Raza Malik ◽  
Jonathan Pierce

AbstractPortal hypertension is a severe, yet common sequela of patients with chronic liver disease and is responsible for many of the complications seen in this population. Measurement of the hepatic venous pressure gradient (HVPG) is the current gold standard technique for identifying and evaluating the severity of portal hypertension. Any increase in HVPG to ≥10 mm Hg is considered clinically significant portal hypertension. Above this threshold, complications of portal hypertension begin to manifest. In addition to assessing portal hypertension, various HVPG thresholds have been shown to have strong prognostic value for risk of complications and therapeutic failure, as well as survival in patients with chronic liver disease. These clinical applications include quantification of disease progression and regression in chronic viral hepatitis, acute alcoholic hepatitis, and hepatocellular carcinoma. Other applications include preoperative evaluation of liver resection and transplantation in patients with cirrhosis and hepatocellular carcinoma, assessment of response to therapy for portal hypertension, and identification of the need for transjugular intrahepatic portosystemic shunt (TIPS) revision.


2009 ◽  
Vol 85 (1000) ◽  
pp. 64-68 ◽  
Author(s):  
Y H Yin ◽  
Z J Ma ◽  
Y H Guan ◽  
Y D Ren ◽  
Z L Zhang

1997 ◽  
Vol 12 (2) ◽  
pp. 176-181 ◽  
Author(s):  
HIROSHI SAKUGAWA ◽  
HIROKI NAKASONE ◽  
FUKUNORI KINJO ◽  
ATSUSHI SAITO ◽  
YOSHIHIDE KEIDA ◽  
...  

Kanzo ◽  
1992 ◽  
Vol 33 (12) ◽  
pp. 981-982
Author(s):  
Hiroshi NISHIMORI ◽  
Shuji NAMBU ◽  
Masami MINEMURA ◽  
Kazuhiko OKADA ◽  
Takashi TSUKISHIRO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document